Eldridge George A's Form 4 filing
Jade Biosciences, Inc. (JBIO) · filed Nov 22, 2022
- Accession no.
- 0001415889-22-011708
- Filed
- Nov 22, 2022
- Trade date
- Nov 18-22, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 7 non-derivative transactions and 3 derivative transactions. Open-market sales total $20.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Eldridge George ACIK 0001413006 | Officer (SEE REMARKS) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2022 | Common Stock | MOption exerciseAcquired | +861 | $2.14 | +$1,842.54 | 2,821 | Direct | |
| Nov 18, 2022 | Common Stock | SSaleDisposed | −780 | $19.45 | −$15,171 | 2,041 | Direct | |
| Nov 18, 2022 | Common Stock | SSaleDisposed | −81 | $20.13 | −$1,630.53 | 1,960 | Direct | |
| Nov 21, 2022 | Common Stock | MOption exerciseAcquired | +2 | $2.14 | +$4.28 | 1,962 | Direct | |
| Nov 21, 2022 | Common Stock | SSaleDisposed | −2 | $19.00 | −$38 | 1,960 | Direct | |
| Nov 22, 2022 | Common Stock | MOption exerciseAcquired | +174 | $2.14 | +$372.36 | 2,134 | Direct | |
| Nov 22, 2022 | Common Stock | SSaleDisposed | −174 | $19.01 | −$3,307.74 | 1,960 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2022 | Common Stock | MOption exerciseDisposed | −861 | $0.00 | $0 | 97,815 | Direct | |
| Nov 21, 2022 | Common Stock | MOption exerciseDisposed | −2 | $0.00 | $0 | 97,813 | Direct | |
| Nov 22, 2022 | Common Stock | MOption exerciseDisposed | −174 | $0.00 | $0 | 97,639 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.